A New Collaboration Will Support Research of Prader-Willi Syndrome and Other Rare Diseases
Vanderbilt University has just announced a new collaborative agreement with Soleno Therapeutics in aim to develop KATP channel activators as a therapeutic for rare diseases. This therapy has already been…